Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | PRKDC | P78527 | 1/20 | 0.33 |
| ▸ | AHR | P35869 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.32 |
| ▸ | MMP12 | P39900 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27017931 | 0.94 | MMP12 (0.35) | ALOX5PRKDCAHRKDM4EMEN1 | |
| SCHEMBL27018870 | 0.92 | MMP12 (0.36) | ALOX5PRKDCAHRKDM4EMEN1 | |
| SCHEMBL27017862 | 0.91 | MMP12 (0.36) | ALOX5PRKDCAHRKDM4EMEN1 | |
| SCHEMBL27017857 | 0.91 | MMP12 (0.36) | ALOX5PRKDCAHRKDM4EMEN1 | |
| SCHEMBL24856434 | 0.91 | AHR (0.35) | ALOX5PRKDCAHRKDM4EMEN1 | |
| SCHEMBL27017944 | 0.90 | MMP12 (0.36) | ALOX5PRKDCAHRKDM4EMEN1 | |
| SCHEMBL27017760 | 0.90 | ALOX5 (0.35) | ALOX5PRKDCAHRKDM4EMEN1 | |
| SCHEMBL27017770 | 0.89 | MMP12 (0.36) | ALOX5PRKDCAHRKDM4EMEN1 | |
| SCHEMBL27017902 | 0.89 | MMP12 (0.34) | ALOX5PRKDCAHRKDM4EMEN1 | |
| SCHEMBL25579339 | 0.88 | MMP12 (0.36) | ALOX5PRKDCAHRKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240023428-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2024-01-18 | — | — | US | disclosed |
| US-20240023428-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2024-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240023428-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | L1CAM, EPCAM, SELE | ALOX5 1055/4885PRKDC 2600/4885AHR 4654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.